Denette K Murphy

Title: Denette K Murphy: Innovator in Selective Estrogen Receptor Modulators

Introduction

Denette K Murphy is a prominent inventor based in Bear, Delaware. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor modulators. Her work has the potential to impact the treatment of various cancers and other health conditions.

Latest Patents

Denette holds 1 patent for her invention titled "Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators." This invention focuses on novel salt forms of triphenylethylene compounds, such as 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic acid. The applications of her invention include methods for the treatment and prevention of breast, uterine, ovarian, prostate, and colon cancer, as well as osteoporosis, cardiovascular disease, and benign proliferative disorders. Additionally, she has developed pharmaceutical compositions based on these compounds.

Career Highlights

Denette K Murphy is associated with Bristol-Myers Squibb Pharma Company, where she has been able to leverage her expertise in pharmaceutical innovation. Her work has contributed to advancements in medical treatments and has positioned her as a key figure in her field.

Collaborations

Denette has collaborated with notable colleagues, including Gary Avonn Cain and Reginald O Cann. These partnerships have enhanced her research and development efforts, leading to impactful innovations in the pharmaceutical industry.

Conclusion

Denette K Murphy's contributions to the field of selective estrogen receptor modulators exemplify her dedication to advancing medical science. Her innovative work continues to pave the way for new treatments that can improve patient outcomes.